Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy

Biomarker-driven trials hold promise for therapeutic development in chronic diseases, such as muscular dystrophy. Myotonic dystrophy type 1 (DM1) involves RNA toxicity, where transcripts containing expanded CUG-repeats (CUG(exp)) accumulate in nuclear foci and sequester splicing factors in the Muscl...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanner, Matthew K, Tang, Zhenzhi, Thornton, Charles A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
RNA and RNA-protein complexes
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913682/
https://www.ncbi.nlm.nih.gov/pubmed/33503262
http://dx.doi.org/10.1093/nar/gkab022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7913682/
https://www.ncbi.nlm.nih.gov/pubmed/33503262
http://dx.doi.org/10.1093/nar/gkab022

Ejemplares similares